Florida Academic Dermatology Center

Phase 3 Studies Comparing Brodalumab with Ustekinumab in Psoriasis

Mark Lebwohl, Bruce Strober, Alan Menter et al. · New England Journal of Medicine · 2015 · 790 citations · Full text

Two Phase 3 Trials of Adalimumab for Hidradenitis Suppurativa

Alexa B. Kimball, Martin M. Okun, David Williams et al. · New England Journal of Medicine · 2016 · 741 citations

Infliximab therapy for patients with moderate to severe hidradenitis suppurativa: A randomized, double-blind, placebo-controlled crossover trial

Annika Grant, Tayler Gonzalez, Michael O. Montgomery et al. · Journal of the American Academy of Dermatology · 2010 · 408 citations

Rheumatology, Systemic Treatment, Clinical Dermatology +5

Adalimumab for the Treatment of Moderate to Severe Hidradenitis Suppurativa

Alexa B. Kimball, Francisco A. Kerdel, David R. Adams et al. · Annals of Internal Medicine · 2012 · 406 citations

Drug survival of biologic therapy in a large, disease‐based registry of patients with psoriasis: results from the Psoriasis Longitudinal Assessment and Registry (PSOLAR)

Alan Menter, Kim Papp, Melinda Gooderham et al. · Journal of the European Academy of Dermatology and Venereology · 2016 · 240 citations · Full text